Medical Receivables Yield Fund returned 12.2% in 2025

Proof Capital's Medical Receivables Yield Fund returned 12.2% in 2025 on its Class F (USD) units, net of fund expenses, according to its overview as of December 31, 2025.
- 2025 return: 12.2%
- 2024 return: 15.6%
- 2023 return: 12.0%
- Net annualized since inception: 13.9%
The fund holds secured high yield loans and profit sharing agreements backed by insured North American medical receivables. It is open-ended, investors can redeem at the end of any month, and returns are either paid in cash monthly or reinvested.
The fund facts list a 6% hurdle rate with a high water mark. Proof says the fund has had less than a 0.1 correlation to the S&P TSX since inception.